
African Barrick Gold: Investec places both its target price (prev.: 212p) and its sell recommendation under review. Westhouse Securities ups target price from 250p to 285p upgrading from neutral to add. Barclays: Deutsche Bank cuts target price from 300p to 275p staying with its buy recommendation.
- FTSE closes up 23.31 at 6,821.46 - Retail sales in surprise dip - Fitch comments lift banking sector techMARK 2,822.06 -0.05% FTSE 100 6,821.46 +0.34% FTSE 250 15,748.69 +0.14% London-listed stocks ended the day higher following a relatively steady morning of gains and a slight dip mid afternoon
Reed Elsevier was the top riser after it reported a 4% increase in half year revenue at constant currency and a 5% increase in the dividend. Shares in International Airlines Group climbed after an agreement was reached between the group and its main trade unions that could see as many as 1,427 job
LONDON, July 24 (Reuters) - British low cost carrier easyJet said it will resume flights to Tel Aviv as scheduled from Friday 25 July after regulators lifted advice over flying into the Israeli airport. easyJet said it would operate a flight from Tel Aviv to London on Thursday afternoon, b
Recent share-price weakness and a positive third-quarter trading update at Easyjet has prompted Panmure Gordon to lift its stance on the stock from 'hold' to 'buy'. "Even though we are likely to trim our earnings forecasts reflecting the more challenging revenue environment, we remain hugely optimi
- Banking, housing stocks provide a boost - Kingfisher, Easyjet slump after results - Ukraine still in focus as Russian sanctions discussed - Eurozone PMI improves, UK retail sales fall techMARK 2,821.65 -0.06% FTSE 100 6,802.89 +0.07% FTSE 250 15,726.48 0.00% UK stocks managed to turn around afte
Recent share-price weakness and a positive third-quarter trading update at Easyjet has prompted Panmure Gordon to lift its stance on the stock from 'hold' to 'buy'. The target price for the shares was left unchanged at 1,800p. The broker said that third-quarter revenue-per-seat growth of 2.7% at c